Science and Technology Committee (Commons)

Genomics and genome editing in the NHS inquiry

Inquiry status: open

The deadline for written submissions has passed. If you would like to send a late submission please contact Committee staff.

Scope of the inquiry

This inquiry examines the Chief Medical Officer's (Dame Sally Davies) call in her latest annual report, ‘Generation Genome’, for mainstreaming genomic medicine in the NHS within 5 years.

The Committee is now inviting written evidence by 13 October on the Chief Medical Officer’s recommendations, including from those who have already submitted evidence to the previous Committee.

This includes observations on how any barriers to greater integration of genomic therapies in the NHS could be overcome, and how such barriers may differ across the devolved nations.

In doing so, the Committee will take forward the interim report from the previous Committee on Genomics and gene-editing and the evidence it had received before the General Election

Terms of reference: Genomics and genome editing in the NHS

Latest evidence

  • 28 Nov 2017 - Genomics and genome editing in the NHS - oral evidence | PDF version (PDF321 KB) HC 349 | Published 12 Dec 2017

    Evidence given by Dr Hilary Burton, Consultant in Public Health, PHG Foundation, Professor Sian Ellard, Clinical Programme Director, South West NHS Genomic Medicine Centre, and Fiona Murphy, Director, National Services Division, NHS National Services Scotland, and Member of the Scottish Genomes Partnership; Lord O’Shaughnessy, Parliamentary Under-Secretary of State, Department of Health, Professor Dame Sally Davies, Chief Medical Officer for England, and Professor Patrick Chinnery, Professor of Neurology, Cambridge University

    Watch this evidence session

Next meeting(s)

There are currently no public meetings scheduled.

Receive RSS updates

Share this page